Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 422.9 INR 2.3%
Market Cap: 254.9B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Wall Street
Price Targets

NATCOPHARM Price Targets Summary
Natco Pharma Ltd

Wall Street analysts forecast NATCOPHARM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 1 288.57 INR with a low forecast of 696.9 INR and a high forecast of 1 758.75 INR.

Lowest
Price Target
696.9 INR
51% Downside
Average
Price Target
1 288.57 INR
9% Downside
Highest
Price Target
1 758.75 INR
24% Upside
Natco Pharma Ltd Competitors:
Price Targets
603998
Hunan Fangsheng Pharmaceutical Co Ltd
24% Upside
ERIS
Eris Lifesciences Ltd
3% Upside
DERM
Journey Medical Corp
71% Upside
UCB
Ucb SA
7% Downside
MYX
Mayne Pharma Group Ltd
17% Upside
053030
Binex Co Ltd
88% Upside
VIRP
Virbac SA
19% Upside
ZTS
Zoetis Inc
28% Upside

Revenue
Forecast

Revenue Estimate
Natco Pharma Ltd

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is -2%.

18%
Past Growth
-2%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Natco Pharma Ltd

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's operating income is 28%. The projected CAGR for the next 3 years is -22%.

28%
Past Growth
-22%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Natco Pharma Ltd

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's net income is 31%. The projected CAGR for the next 3 years is -16%.

31%
Past Growth
-16%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NATCOPHARM's stock price target?
Price Target
1 288.57 INR

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 1 288.57 INR with a low forecast of 696.9 INR and a high forecast of 1 758.75 INR.

What is Natco Pharma Ltd's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is -2%.

What is Natco Pharma Ltd's Operating Income forecast?
Projected CAGR
-22%

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's operating income is 28%. The projected CAGR for the next 3 years is -22%.

What is Natco Pharma Ltd's Net Income forecast?
Projected CAGR
-16%

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's net income is 31%. The projected CAGR for the next 3 years is -16%.

Back to Top